Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,529.50
Bid: 1,531.50
Ask: 1,532.00
Change: 3.50 (0.23%)
Spread: 0.50 (0.033%)
Open: 1,537.00
High: 1,541.50
Low: 1,523.00
Prev. Close: 1,526.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-JD Sports leads FTSE 100 higher, rate cut hopes support

Tue, 10th Sep 2019 09:46

* FTSE 100 up 0.4%, FTSE 250 up 0.3%

* JD Sports hits life high after profit rise

* Galliford jumps on deal talks

* 888 skids as earnings hit by higher tax, Brexit-related
expenses
(Adds new items, analyst comments, updates to closing prices)

By Muvija M and Shashwat Awasthi

Sept 10 (Reuters) - London's FTSE 100 overcame early losses
to close higher on Tuesday as hopes of imminent interest rate
cuts from major central banks buoyed sentiment, while JD Sports
jumped to an all-time high on upbeat results.

The blue-chip index added 0.4%, with JD Sports
gaining 8.8% after its gym clothing and premium-branded
fashion helped it post higher profit and offset UK retail sector
gloom.

The FTSE 250 rose 0.3%, helped in part by a nearly
13% surge in Cairn Energy as strong half-year results
led to a production target upgrade.

In a sign of ongoing rotation, investors dumped defensive
shares and bought stocks of sectors that have underperformed
this year, helping an index of banks climb 2.4% for
its best day since January.

Shares of Lloyds and Barclays rose 4.3%
and 4.9%, respectively, while healthcare stocks GlaxoSmithKline
and AstraZeneca shed more than 2% each.

UK markets also looked past disappointing data from China
overnight that had added to fears of a global recession.

Speculation that the European Central Bank will cut interest
rates this week and that the U.S. Federal Reserve will follow
suit later this month in the face of slowing economic growth
helped stoke some risk appetite.

"Seeing as the ECB are tipped to go down the path of an
interest rate cut, stocks are likely to be buoyant between now
and the announcement," CMC Markets analyst David Madden said.

Oil heavyweights Shell and BP were the
biggest boosts to the main index as they tracked a rise in crude
prices on hopes that OPEC and other oil-producing countries may
agree to extend output cuts to prop up prices.

Mid-cap builder Galliford Try advanced 8% after it
restarted preliminary talks to sell its residential housing
businesses to Bovis Homes.

Bovis, whose shares dropped 3.5%, nudged up its proposed
offer and included a cash element, which Markets.com analyst
Neil Wilson said would be "a welcome injection for the newly
reorganised Galliford construction division."

Among small-caps, online gambling firm 888 Holdings
slumped 8.6%, its worst day in almost a year, after results
showed a hit to earnings from a rise in online gaming taxes and
administrative expenses due to Brexit preparations.
(Reporting by Muvija M in Bengaluru; Editing by Arun Koyyur and
Dan Grebler)

More News
18 Sep 2023 07:18

US FDA approves GSK treatment for myelofibrosis

(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.

Read more
15 Sep 2023 21:52

GSK's Ojjaara approved in US for myelofibrosis patients with anaemia

(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.

Read more
11 Sep 2023 08:24

Japan accepts GSK's regulatory filing for momelotinib for blood cancer

(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.

Read more
11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

Read more
6 Sep 2023 09:32

LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
4 Sep 2023 06:00

More UK babies to need hospital treatment over delay of GSK's RSV jab

(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.

Read more
1 Sep 2023 09:11

GSK antibody accepted for Japan review, Goldman Sachs reduces stake

(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.

Read more
1 Sep 2023 07:49

LONDON BRIEFING: Stocks seen higher; UK house prices continue to fall

(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.

Read more
1 Sep 2023 07:12

Japan considering GSK's Nucala drug for sinusitis treatment

(Sharecast News) - Japanese regulators are reviewing a new drug application for GSK's Nucala treatment to be used for the treatment of form of adult sinusitis, the biopharma giant announced on Friday.

Read more
23 Aug 2023 12:10

LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data

(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.

Read more
23 Aug 2023 08:17

GSK gets positive results from shingles trial of Shingrix in China

(Alliance News) - GSK PLC on Wednesday celebrated positive results from the first-ever efficacy trial of its preventative shingles treatment, Shingrix, in China.

Read more
23 Aug 2023 07:04

GSK reports positive results from shingles vaccine trials in China

(Sharecast News) - GSK reported significant positive findings from its first efficacy trial of the 'Shingrix' shingles vaccine in China on Wednesday.

Read more
22 Aug 2023 13:09

UK's Wood Group raises profit forecast on contract wins; shares rise

CFO David Kemp to retire

*

Read more
21 Aug 2023 22:37

US FDA approves Pfizer's maternal RSV vaccine to protect infants

Aug 21 (Reuters) - The U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.

Read more
17 Aug 2023 19:53

Charity says HIV drug deal with GSK's ViiV on ice over price secrecy

(Alliance News) - The Doctors Without Borders, or MSF, charity said Thursday a deal aimed to bring long-term preventative HIV treatment to vulnerable populations was on hold after the drugmaker imposed pricing confidentiality.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.